These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22552262)

  • 1. Botulinum neurotoxin A: a review.
    Berry MG; Stanek JJ
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1283-91. PubMed ID: 22552262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the use of botulinum neurotoxins in facial esthetics.
    Flynn TC
    J Cosmet Dermatol; 2012 Mar; 11(1):42-50. PubMed ID: 22360334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on neurotoxins for facial rejuvenation: what they are, how they work, and how to effectively and safely use them.
    Brennan C
    Plast Surg Nurs; 2015; 35(2):69-75. PubMed ID: 26020471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of clinical trial data on a new formulation of botulinum neurotoxin type A.
    Jewell ML; Monheit GD
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S31-3. PubMed ID: 19945002
    [No Abstract]   [Full Text] [Related]  

  • 5. The continuing evolution of neurotoxins for nonsurgical facial rejuvenation: an introduction.
    Matarasso A
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S29-30. PubMed ID: 19945001
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of periorbital rhytids with botulinum toxin type A: maximizing safety and results.
    Spiegel JH
    Arch Facial Plast Surg; 2005; 7(3):198-202. PubMed ID: 15897411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin products overview.
    Carruthers A; Carruthers J
    Skin Therapy Lett; 2008; 13(6):1-4. PubMed ID: 18806905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of quality of patient information regarding Botox(®) cosmetic on the internet.
    Grippaudo FR; Atzeni M; Santanelli di Pompeo F
    J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):e64-6. PubMed ID: 26776351
    [No Abstract]   [Full Text] [Related]  

  • 9. Facial filler and neurotoxin complications.
    Nettar K; Maas C
    Facial Plast Surg; 2012 Jun; 28(3):288-93. PubMed ID: 22723229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Aesthetics Consensus: Botulinum Toxin Type A--Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications.
    Sundaram H; Signorini M; Liew S; Trindade de Almeida AR; Wu Y; Vieira Braz A; Fagien S; Goodman GJ; Monheit G; Raspaldo H;
    Plast Reconstr Surg; 2016 Mar; 137(3):518e-529e. PubMed ID: 26910696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Techniques for Neurotoxin Outcomes.
    Brown L; Taylor D; Weiss E
    Dermatol Surg; 2018 May; 44(5):721-725. PubMed ID: 29315143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New neurotoxins on the horizon.
    Freeman SR; Cohen JL
    Aesthet Surg J; 2008; 28(3):325-30. PubMed ID: 19083544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid filler and botulinum Neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy.
    Kenner JR
    J Drugs Dermatol; 2010 Sep; 9(9):1135-8. PubMed ID: 20865847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes.
    Chang BL; Wilson AJ; Taglienti AJ; Chang CS; Folsom N; Percec I
    Aesthet Surg J; 2016 Jul; 36(7):810-20. PubMed ID: 26780945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part I: Upper facial wrinkles.
    Ascher B; Talarico S; Cassuto D; Escobar S; Hexsel D; Jaén P; Monheit GD; Rzany B; Viel M
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1278-84. PubMed ID: 20337830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial rejuvenation using neurotoxins and injectable fillers.
    Niamtu J
    Gen Dent; 2013; 61(7):38-46. PubMed ID: 24192733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A for aging face and aesthetic uses.
    Hexsel C; Hexsel D; Porto MD; Schilling J; Siega C
    Dermatol Ther; 2011; 24(1):54-61. PubMed ID: 21276158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mind, Mood, and Aesthetics.
    Dayan SH
    Aesthet Surg J; 2015 Aug; 35(6):759-61. PubMed ID: 26044342
    [No Abstract]   [Full Text] [Related]  

  • 19. [Wrinkle fillers in cosmetic facial procedures].
    Jaspers GW; Schepers RH; Pijpe J; Jansma J
    Ned Tijdschr Tandheelkd; 2014 May; 121(5):269-74. PubMed ID: 24881255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxin type A in facial aesthetics.
    De Boulle KL
    Expert Opin Pharmacother; 2007 Jun; 8(8):1059-72. PubMed ID: 17516871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.